Clinical Trial Update: Botulinum A Toxin in Patients With Parkinson's Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating botulinum toxin type A in patients with Parkinson's disease and related conditions; trial status is unspecified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Detrusor Overactivity
• Multiple System Atrophy
• Parkinson Disease

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: University Of Perugia | Conditions: Parkinson's Disease, Multiple System Atrophy | Phase 4 | Status: UNKNOWN